ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $511,000 | -10.9% | 20,000 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $573,600 | +19.6% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $479,400 | +41.3% | 20,000 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $339,200 | -99.9% | 20,000 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $296,400,000 | +93995.2% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $315,000 | -41.6% | 20,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $539,000 | -63.6% | 20,000 | -50.0% | 0.00% | -20.0% |
| Q4 2021 | $1,480,000 | +54.8% | 40,000 | +100.0% | 0.01% | -50.0% |
| Q3 2021 | $956,000 | +41.2% | 20,000 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $677,000 | -18.0% | 20,000 | 0.0% | 0.01% | -27.3% |
| Q1 2021 | $826,000 | -4.8% | 20,000 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $868,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |